‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
30
00:00:00
/ 00:19:09
30